患有中央血清性胆色素变异症的患者在循环中具有高的α-klotho度
Eri Tahara1, Yuki Yamamoto1, Takaaki Sugisawa1
1Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
PloS one
|December 21, 2023
概括
血液中α-klotho (αKl) 水平升高可能表明中央血清性胆色素变异症 (CSC) 患者的压力. 这项研究发现,与健康个体相比,CSC患者的αKl度更高,这表明αKl是CSC潜在的压力生物标志物.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 生物标志物研究 生物标志物研究
背景情况:
- 压力是已知的中央血清性胆色素变异症 (CSC) 的风险因素.
- 在CSC患者中缺乏绝对的压力生物标志物.
- 阿尔法-克洛托 (αKl) 是一种蛋白质激素,在应激反应中具有潜在的作用.
研究的目的:
- 研究α-klotho (αKl) 作为中枢血清性胆色素变异 (CSC) 中压力的潜在生物标志物.
- 为了在CSC患者和健康对照者之间比较循环中的αKl度.
- 分析与CSC亚型 (急性与慢性) 和复发相关的αKl水平.
主要方法:
- 在56名骨髓瘤患者和27名健康对照人群中,对αKl度的回顾性分析.
- 在急性CSC,慢性CSC和对照组之间比较αKl水平.
- 评估αKl,年龄,性别,吸烟状况和亚叶胆道厚度 (SFCT) 之间的相关性.
主要成果:
- 在CSC患者 (827±232 pg/mL) 中,循环中的αKl度明显高于对照组 (724±183 pg/mL).
- 与慢性CSC (740±224 pg/mL) 患者相比,急性CSC患者的αKl水平较高 (898±221 pg/mL).
- 在经历了复发的CSC患者中观察到更高的αKl度.
结论:
- 循环中的αKl度升高与中央血清性胆色素变异 (CSC) 有关.
- 在CSC患者中,αKl可以作为潜在的压力生物标志物.
- 需要进一步的研究来阐明αKl在CSC病变发生过程中的确切作用.
相关概念视频
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...